CHRS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coherus Oncology Inc

Watchlist Manager

Watchlist

Price: 1.065 USD -4.91% Market Closed

Market Cap: $164.3m

	Coherus Oncology Inc NASDAQ:CHRS	US
N	NSK Ltd DUS:NSK	JP
	Oesterreichische Post AG F:O3P	AT
V	Voyageur Pharmaceuticals Ltd OTC:VYYRF	CA
S	Sintrones Technology Corp TPEX:6680	TW
	Casio Computer Co Ltd TSE:6952	JP
B	Bathurst Resources Ltd F:B0R	NZ
	Krasnoyarskenergosbyt PAO MOEX:KRSBP	RU
C	Chaheng Precision Co Ltd TPEX:4546	TW
M	Maqbool Textile Mills Ltd KAR:MQTM	PK
Z	Zen Voce Corp TPEX:3581	TW
	DiaSorin SpA F:34D	IT
	JMDC Inc TSE:4483	JP
T	Tainet Communication System Corp TPEX:4905	TW
S	Sintercom India Ltd NSE:SINTERCOM	IN
	Petroleo Brasileiro SA Petrobras BOVESPA:PETR4	BR

Profitability Summary

Coherus Oncology Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

54%

Gross Margin is Increasing

58% > 69%

Negative Operating Margin

-312%

Negative 3Y Average Operating Margin

-216%

Declining Operating Margin

-86% > -312%

Negative Net Margin

-259%

Strong 3Y Average Net Margin

70%

Declining Net Margin

-103% > -259%

Negative Free Cash Flow Margin

-365%

Negative 3Y Average Free Cash Flow Margin

-134%

Declining Free Cash Flow Margin

-124% > -365%

Negative ROE

-146%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-61%

Declining ROIC

-54% > -134%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.